NHS Golden Jubilee Becomes First Scottish Hospital to Adopt Light-Activated Infection Prevention Technology to Prevent Surgical Site Infections GLASGOW — Scotland’s flagship orthopaedic hospital, NHS Golden Jubilee, has become the first in the country to adopt an...
Receptor.AI and Sethera Partner on AI-Guided Peptide Drug Discovery
Receptor.AI and Sethera Therapeutics Form Integrated Discovery Alliance for AI-Guided Polymacrocyclic Peptide Medicines Collaboration combines Sethera's proprietary enzymatic polymacrocyclisation and trillion-scale encoded screening with Receptor.AI's physics-based...
Why True Health Foods Need Evidence, Not Fashion
Functional foods have entered the mainstream, but adding a recognised ingredient is not the same as creating a credible product. A cardiologist argues that the category’s next phase will be won on scientific rationale, dose and honest communication, not on the length...
How Clinical Research Is Transforming the Future of Sarcoma Care
Rare cancers present one of the greatest challenges in modern oncology. Individually uncommon but collectively accounting for around one in five cancer diagnoses worldwide, they have historically attracted less research funding, fewer clinical trials and limited...
Weekly News Roundup | 03 August 2026
Life science news 3 August 2026: argenx pays $2.2 billion for what it calls a first-in-class anti-CD122 antibody, Johnson & Johnson strikes agreements worth up to $3.5 billion with in vivo CAR-T developer Sail Biomedicines, and GSK launches a £1.9 billion savings...
Measuring the Human Variables Healthcare Systems Continue to Miss
Healthcare organizations have never had more data available to them. Leaders monitor patient satisfaction scores, staffing ratios, productivity, quality indicators, denial rates, wait times, and length of stay. The dashboards are sophisticated, the reporting cadence...
Weekly News Roundup | 30 March 2026
Life science news 30 March 2026: Three blockbuster deals, two FDA accelerated approvals and intensifying GLP-1 competition headline a busy week for pharma and biotech. Merck agreed on 25 March to acquire Terns Pharmaceuticals for $6.7 billion, gaining access to...
Weekly News Roundup | 23 March 2026
Your essential life science news 23 March 2026 digest: the past week’s biggest stories in pharma, biotech and healthcare. The FDA approved Johnson and Johnson's once-daily psoriasis pill ICOTYDE (icotrokinra) on 18 March, making it the world's first oral peptide to...
Power Outages as a Clinical Risk Multiplier in Healthcare
Electricity as a Hidden Dependency in Healthcare Reliable electricity is a foundational requirement for modern healthcare systems. From acute hospital care to long-term residential facilities and home-based treatment, uninterrupted power underpins virtually every...
I’m a Menopause Doctor – Here’s the Real Problem with Fezolinetant
With news of a HRT alternative for women struggling with hot flushes now available on the NHS, Dr Louise Newson explains why when it comes to Fezolinetant, women need to proceed with caution. UK medicines regulator NICE reported that they're in the final stages of...
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
New research has found that microplastics from food packaging could cause damage to the normal function and health of the liver. Microplastics - small fragments less than 5mm in size - are already known to be widespread in the food and drink that we consume. It is...
Weekly News Roundup | 16 March 2026
Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Imperial College London, University of Oxford and GSK Launch £11 Million Centre to Build Digital Twins of Human Organs A new research centre backed by £11 million in funding has been established by Imperial College London, the University of Oxford and GSK to develop...
Redefining Fertility & Modern Motherhood with Dr. Roohi Jeelani and Hayley
For many modern women, the concept of fertility is something to consider later, when life feels steady and the timing feels right. Now more than ever, trends that encourage delaying partnership, questioning traditional paths, or seeking information earlier are...
Teaching Children Conscious Self-Regulation for Life Outcomes
A Neurodevelopmental Framework for Strategic Life Construction In an era defined by rapid technological change, algorithmic persuasion, and rising rates of youth anxiety, the question is no longer whether children need education, but what kind of education is most...
Thermo Fisher Scientific Opens New Distribution Center in Ireland
70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...
From Living Room to Lab: New Dementia Study to Close Participation Gap
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...
MSD Reorganises to Shield Growth from Impending “Keytruda Cliff”
In its most significant structural overhaul since the 2021 Organon spin-off, MSD (known as Merck & Co. in the U.S. and Canada) has announced the division of its Human Health business into two standalone units: an Oncology Business Unit and a Specialty, Pharma...







